How to Find an Obesity Medicine Doctor Near Me
You do not always need a specialist to get a weight-loss drug, but the OMA member directory lists obesity medicine clinicians by city, state, or ZIP, and the ABOM Diplomate Search verifies board certification, which requires at least 60 hours of obesity-specific education plus an exam.
Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.
You do not necessarily need an obesity medicine specialist to get a weight-loss medication. Family physicians are often the first line of treatment in the healthcare setting, which gives them early opportunities to prevent and treat overweight and obesity [2], and telehealth platforms have made GLP-1 prescriptions faster and easier to obtain [4]. But if you want a clinician with specific training in obesity, there are two free places to start: the Obesity Medicine Association (OMA) member directory, which you can search by city, state, or ZIP code [1], and the American Board of Obesity Medicine (ABOM) Diplomate Search on abom.org, which verifies a physician’s certification [3].
This page walks through what these credentials actually mean, how to run the searches, how to spot marketing pages posing as clinics, and what to ask before you book a visit.
What is an obesity medicine clinician?
Obesity medicine clinicians treat obesity as a disease. The OMA defines obesity as a “serious, chronic, progressive, relapsing, and treatable multi-factorial, neurobehavioral disease…” in which increased adiposity promotes adipose tissue dysfunction and abnormal fat mass physical forces [2]. Because many different factors contribute to obesity, these clinicians build personalized treatment plans made up of nutrition, physical activity, behavior therapy, and medication [1].
OMA members include physicians, nurse practitioners, physician assistants, and other healthcare providers who have received specialized training to treat obesity and obesity-related conditions [1]. The OMA is a United States-based medical society with over 5,000 members at the time of print in 2025 [2].
A joint clinical perspective from the OMA and the American College of Osteopathic Family Physicians (ACOFP), which represents more than 26,000 practicing osteopathic family physicians, residents, students, and allied health professionals, describes obesity care as resting on 4 pillars: nutrition therapy, physical activity, behavior modification, and medical interventions, which include anti-obesity medications and bariatric surgery [2].
What does ABOM board certification mean?
ABOM certification is a physician credential that signifies specialized knowledge in the practice of obesity medicine and distinguishes a physician as having achieved competency in obesity care [3]. The OMA describes an ABOM Diplomate as a doctor who has completed at least 60 hours of obesity-specific education and passed the ABOM certification exam [1].
To even apply, a physician must meet minimum requirements: an active, unrestricted medical license in the U.S. or Canada (training licenses are not accepted), proof of completion of a residency in the U.S. or Canada, and active board certification in an American Board of Medical Specialties (ABMS) member board or the osteopathic medicine equivalent. Certification is only available to physicians trained and practicing in the U.S. or Canada [3].
There are two pathways. Under the CME pathway, a physician must earn 60 CME credits; any Group Two CME must be AMA PRA Category 1 Credit and each activity must include the word “obesity” in its title [3]. Under the fellowship pathway, a physician must also show successful completion of an Obesity Medicine Fellowship Council–recognized fellowship, with the completion date falling within the 36 months before the exam application deadline [3].
The exam is offered once a year at Pearson VUE computer-based test centers throughout the U.S. and Canada. The 2027 test window runs October 12–26, 2027, with an early application deadline of July 10, 2027 ($1,500 fee) and a final deadline of August 7, 2027 ($1,750 fee) [3].
A separate credential, Fellow of OMA, is open to physicians, nurse practitioners, and physician assistants who have demonstrated an ongoing commitment to the practice of obesity medicine and completed at least 75 hours of advanced training in obesity medicine [1].
| Credential | Who holds it | What it requires |
|---|---|---|
| OMA member | Physicians, NPs, PAs, other providers | Specialized training in obesity and obesity-related conditions [1] |
| ABOM Diplomate | Physicians only | At least 60 hours of obesity-specific education plus the ABOM exam [1][3] |
| Fellow of OMA | Physicians, NPs, or PAs | At least 75 hours of advanced obesity medicine training and ongoing commitment to the practice [1] |
How do I run the directory searches and verify a doctor?
Start with the OMA member directory at obesitymedicine.org. Search by city, state, or ZIP code for an obesity medicine clinician in your area [1]. The directory has filter options, including “ABOM Diplomate” and “Fellow of OMA,” so you can narrow results to clinicians holding those credentials [1].
One thing to keep in mind: this is OMA’s member directory, so it lists members only [1]. A clinician who is not an OMA member will not appear in it, so an empty result does not tell you whether qualified clinicians practice in your area.
Next, verify the credential. The ABOM Diplomate Search on abom.org is the certification verification tool. If a doctor’s website says they are “board certified in obesity medicine,” you can confirm that claim here [3].
There is a third option as well. The OMA partnered with the Obesity Action Coalition to include OMA members in the Obesity Care Provider Database at obesitycareproviders.com, which lists obesity doctors, nurse practitioners, physician assistants, dietitians, and bariatric surgeons near you [1]. This one is useful if you want to find dietitians or surgeons alongside a prescribing clinician.
How do I tell a credentialed clinic from a marketing page?
A checkable credential is the first test. “Board certified in obesity medicine” is verifiable through the ABOM Diplomate Search; vague labels like “weight-loss expert” are not credentials [3].
The FDA has also flagged specific marketing practices among telehealth companies that sell compounded drugs. The agency warns that telehealth firms must not use branding that falsely implies the company is the compounder, and must not describe a compounded drug as a generic version of, or the same as, an FDA-approved drug [9]. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before marketing [9].
The FDA has issued warning letters to telehealth companies over false or misleading claims, and those letters are searchable using the term “telehealth” in the FDA’s warning letter database [9].
Does the practice include nutrition and behavioral support?
A 2026 article in the Journal of Medical Internet Research reports that telehealth platforms do not always offer the nutrition, exercise, and behavioral guidance needed to lose weight safely, and that as a result, some patients lose lean tissue and experience micronutrient deficiencies [4].
The numbers behind that concern come from a 2026 scoping review in Obesity Reviews that examined 12 clinical trials of patients taking GLP-1 medications. Participants reduced their caloric intake by 24% to 39% and lost significant weight, but 40% of the weight lost was lean tissue. Only 3 of the 12 studies involved a registered dietitian, and one study found nutrient inadequacies [4].
That does not mean telehealth care is ineffective. A large study of more than 50,000 participants using telehealth-delivered GLP-1 medications found weight loss of 8.9% at 3 months and 19% at 12 months, results similar to those of major clinical trials [4]. The gap is in support, not in the prescription itself. Integrating registered dietitians and other health professionals into these programs can help patients make the sustainable changes needed to maximize the benefits of GLP-1 medications [4].
One registered dietitian quoted in the article put the difference plainly: the major advantage of a traditional clinical setting is interdisciplinary team care involving a primary care physician, cardiologist, and endocrinologist, which is harder to get from an online-only company [4].
So before booking, ask whether nutrition and behavioral support is included, and whether a registered dietitian is part of the practice.
What should a first visit cover?
The American Diabetes Association’s Standards of Care in Diabetes–2026, section 8, covers obesity and weight management specifically for the prevention and treatment of diabetes, so its recommendations are written for people with or at risk of diabetes. Even so, it offers a useful checklist for what structured obesity care looks like.
The ADA recommends person-centered, nonjudgmental, person-first language, such as “person with obesity” rather than “obese person” [7]. Screening for overweight and obesity should use BMI annually, and additional assessments of body fat using anthropometric measures like waist-to-hip ratio or direct measurements could be considered where available and feasible to confirm excess adiposity [7]. By BMI categories, overweight is 25–29.9 kg/m2, obesity class 1 is 30–34.9, class 2 is 35–39.9, and class 3 is 40 and above. A BMI of 30 kg/m2 and above is the obesity threshold [7].
Measurements should be monitored at least annually, and at least every 3 months during active weight management treatment [7]. The ADA also says accommodations should be made to provide privacy during anthropometric measurements [7].
On treatment, the ADA recommends individualizing the initial approach among lifestyle and nutritional therapy, pharmacologic therapy, and metabolic surgery based on the person’s medical history, life circumstances, and preferences, and considering combining approaches if appropriate [7]. For context on goals in the diabetes population the guidance addresses, weight loss of 5–7% of baseline weight improves glycemia and other intermediate cardiovascular risk factors, and sustained loss of more than 10% of body weight usually confers greater benefits, including disease-modifying effects and possible remission of type 2 diabetes [7].
One caveat on BMI: the ADA notes it is prone to misclassification in people who are very muscular and in those with low muscle mass [7].
What will it cost, and will insurance cover it?
Visit fees, membership prices, and program costs vary and are not published in the sources here, so treat them as questions to ask each practice directly. What is published is employer drug coverage data.
A Business Group on Health survey completed in February–March 2026 by 105 employer members found that 67% of surveyed employers currently cover GLP-1s for weight management [8]. Of those covering them, 72% said they were likely to continue that coverage in 2027, while 10% said they likely would not [8].
Employers also use strategies that can affect what you need from your doctor: validating clinical eligibility through objective biometric data, requiring participation in a weight management program to receive coverage, limiting prescribing to specific providers, and excluding certain medications from the formulary [8].
| Survey finding (105 employers, February–March 2026) | Result |
|---|---|
| Currently cover GLP-1s for weight management | 67% [8] |
| Of those covering, likely to continue in 2027 | 72% [8] |
| Of those covering, likely to discontinue | 10% [8] |
| Use standard cost-share arrangement for these drugs | 83% [8] |
| Say GLP-1s are increasing company health care costs | Nearly 8 in 10 [8] |
| Expect oral GLP-1 availability to raise demand | 87% [8] |
Because of strategies like these, questions worth asking before you start include what biometric documentation your plan requires, whether it requires participation in a weight management program, and whether it limits prescribing to specific providers [8].
Do I need a specialist, or can my primary care doctor handle this?
There is no single answer, but the OMA/ACOFP paper is clear that primary care is a legitimate setting for obesity treatment. Family physicians are often the first line of treatment, and patient care is enhanced when primary care clinicians recognize the risks and benefits of anti-obesity medications and bariatric procedures, along with providing long-term follow-up [2].
The ADA guidance supports individualizing the initial approach among lifestyle therapy, pharmacotherapy, and metabolic surgery rather than defaulting to any one of them [7]. For comparison, metabolic surgery results in an average of more than 20% body weight loss and often leads to remission of diabetes [7].
The same OMA/ACOFP paper names the barriers that can limit primary care obesity treatment: inadequate training, insufficient time, lack of adequate reimbursement, insufficient access to treatment resources, and the adverse impact of bias, stigma, and discrimination [2].
What if there is no obesity medicine doctor near me?
Telehealth has broadened GLP-1 access beyond specialist-managed diabetes care, making prescriptions faster and easier to obtain, though financial barriers remain for some patients [4]. In one study currently available as a preprint, telehealth patients on semaglutide achieved weight loss comparable to clinical trial benchmarks, while patients on tirzepatide fell short of that standard, possibly due to the higher cost of a clinical dosage of tirzepatide [4].
If you would rather stay local, the OMA directory is searchable by city and state as well as ZIP code, so widening the search area may surface clinicians a short drive away [1].
A checklist for choosing and vetting a doctor
- Search the OMA member directory by ZIP code, and filter for “ABOM Diplomate” or “Fellow of OMA” if you want those credentials [1].
- Verify the doctor’s name in the ABOM Diplomate Search on abom.org [3].
- Ask whether nutrition and behavioral support, including access to a registered dietitian, is part of the practice [4].
- Ask about insurance and employer-plan requirements, such as program participation or biometric documentation for coverage [8].
- Cross-check the Obesity Care Provider Database at obesitycareproviders.com if you also need dietitians or bariatric surgeons [1].
Sources
- Obesity Medicine Association. Find an Obesity Medicine Provider.
- PMC. Obesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP). 2025.
- American Board of Obesity Medicine. Certifying physicians in the treatment of obesity.
- PMC. After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care.
- DailyMed. WEGOVY (semaglutide) injection, solution; semaglutide tablet. National Library of Medicine.
- Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, for subcutaneous use. Prescribing information. Initial U.S. approval: 2022.
- PMC. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes–2026.
- Business Group on Health. GLP-1 Costs Loom Large for Employers, Forcing Challenging Coverage Decisions, Business Group on Health Survey Finds. 2026.
- US Food and Drug Administration. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs.
- American Board of Obesity Medicine. Stats and Data.
Frequently asked questions
How does ABOM certification relate to ABMS boards?
ABOM is its own certifying body for obesity medicine. To apply, a physician must already hold active board certification in an ABMS member board or the osteopathic medicine equivalent, plus proof of a U.S. or Canada residency and an active, unrestricted license. In other words, diplomates are certified in another specialty first, then add obesity medicine on top of it.
What is the difference between an obesity medicine physician and a bariatric surgeon?
Obesity medicine clinicians treat obesity with nutrition, physical activity, behavior therapy, and medication. Bariatric surgeons perform metabolic surgery, which produces an average of more than 20% body weight loss and often leads to diabetes remission. The Obesity Care Provider Database lists both, plus dietitians.
Can a primary care doctor treat obesity and prescribe anti-obesity medications?
Yes, primary care is a recognized setting for this. Family physicians are often the first line of treatment for overweight and obesity, and patient care is enhanced when primary care clinicians recognize the risks and benefits of anti-obesity medications and bariatric procedures and provide long-term follow-up. Whether a specific doctor prescribes GLP-1s is a question to ask the practice directly.
What does ABOM Diplomate mean?
It means a physician has completed at least 60 hours of obesity-specific education and passed the American Board of Obesity Medicine certification exam. Certification signifies specialized knowledge and competency in obesity care.
What is a Fellow of OMA?
Fellows are physicians, nurse practitioners, or physician assistants who have demonstrated an ongoing commitment to obesity medicine and completed at least 75 hours of advanced training in the field. It is a separate credential from ABOM Diplomate status.
Are these directories open to the public?
Yes. The OMA member directory is a public search tool you can search by city, state, or ZIP code, and the ABOM Diplomate Search on abom.org is a public certification verification tool. The Obesity Care Provider Database is also publicly searchable.
Why does no one show up in my ZIP code search?
The OMA directory lists OMA members only, so a clinician who is not a member will not appear, and the society has over 5,000 members. Try widening your search to your city or state, or check the Obesity Care Provider Database, which also lists dietitians and bariatric surgeons.
Does insurance cover an obesity medicine visit?
What is known is that 67% of 105 surveyed employers cover GLP-1 drugs for weight management, and many require biometric documentation, program participation, or specific prescribers. Ask your plan directly.
This article summarizes FDA labeling, published research and company information current as of September 14, 2026. It is not medical advice and does not replace a conversation with your own healthcare provider. How we research and verify.